Filing Details
IONIS PHARMACEUTICALS INC (NASDAQ:IONS) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on November 09, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:IONS
IONIS PHARMACEUTICALS INC (IONS) Files Quarterly Report for Q0
IONIS PHARMACEUTICALS INC (NASDAQ:IONS) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on November 09, 2026.
At publication ·
What changed
IONIS PHARMACEUTICALS INC (NASDAQ:IONS) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Ionis Pharmaceuticals filed its Q0 quarterly report (Form 10-Q) with the SEC on November 9, 2026.
- The stock trades at $39.42 with a market capitalization of $12.6 billion.
- The 10-Q filing includes unaudited financial statements and management commentary on business performance and emerging trends.
Market Context
IONIS PHARMACEUTICALS INC's stock currently trades at $39.42 with a market capitalization of $12.6B.
The 10-Q provides IONIS PHARMACEUTICALS INC's quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for IONIS PHARMACEUTICALS INC are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View IONS Stock Page
Frequently Asked Questions
Where can I read IONS's SEC filings?
Browse all filings on our IONS SEC filings page.
What types of SEC filings does IONIS PHARMACEUTICALS INC file?
Public companies like IONIS PHARMACEUTICALS INC file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.